Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Novavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

NOVAVAX-COVID-auth

More Like This

ACCESSWIRE logo

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1

ACCESSWIRE logo

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s Updated Covid-19 Vaccine in The European Union

ACCESSWIRE logo

Moderna Submits Regulatory Application to the European Medicines Agency for Its Updated COVID-19 Vaccine

UK Government Strengthens Vaccine Partnership with CSL Seqirus, Introducing World-First Flu vaccine (aTIVc) and Extending Health Security Pandemic Agreement

ACCESSWIRE logo

Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine

ACCESSWIRE logo

Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union

ACCESSWIRE logo

Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R)

Lancet Publication Marks Important Advance in Influenza Prevention for Older Adults

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us